XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net service revenue $ 2,236,382 $ 2,223,199 $ 2,214,112
Other operating income 0 0 13,300
Cost of service, inclusive of depreciation 1,245,509 1,260,425 1,233,356
General and administrative expenses:      
Salaries and benefits 516,049 508,791 474,718
Non-cash compensation 26,082 16,560 23,809
Merger-related expenses 36,672 0 0
Depreciation and amortization 17,747 24,935 30,901
Investment impairment 0 3,009 0
Other 237,929 228,707 212,713
Total operating expenses 2,079,988 2,042,427 1,975,497
Operating income 156,394 180,772 251,915
Other income (expense):      
Interest income 3,270 178 49
Interest expense (31,274) (22,228) (9,525)
Equity in earnings (loss) from equity method investments 10,760 (45) 4,949
Merger termination fee (106,000) 0 0
Gain on equity method investments 0 0 31,098
Miscellaneous, net 6,473 1,567 1,745
Total other (expense) income, net (116,771) (20,528) 28,316
Income before income taxes 39,623 160,244 280,231
Income tax expense (50,559) (42,545) (70,065)
Net (loss) income (10,936) 117,699 210,166
Net loss (income) attributable to noncontrolling interests 1,189 910 (1,094)
Net (loss) income attributable to Amedisys, Inc. $ (9,747) $ 118,609 $ 209,072
Basic earnings per common share:      
Net (loss) income attributable to Amedisys, Inc. common stockholders (usd per share) $ (0.30) $ 3.65 $ 6.41
Weighted average shares outstanding (shares) 32,599 32,517 32,642
Diluted earnings per common share:      
Net (loss) income attributable to Amedisys, Inc. common stockholders $ (0.30) $ 3.63 $ 6.34
Weighted average shares outstanding (shares) 32,599 32,653 32,972